KalVista Pharmaceuticals, Inc. (KALV) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 320.15M | 320.15M | 325.23M | 205.9M | 241.69M | 267.36M | 152.27M | 191.63M | 225.69M | 104.1M | 128.61M | 149.84M |
| Cash & Short-Term Investments | 300.21M | 300.21M | 309.16M | 191.47M | 187.65M | 253.2M | 135.78M | 174.27M | 210.4M | 75.59M | 103.17M | 123.26M |
| Cash Only | 229.34M | 229.34M | 243.5M | 124.3M | 98.64M | 167.29M | 41.58M | 31.85M | 31.79M | 23.06M | 57.67M | 49.41M |
| Short-Term Investments | 70.87M | 70.87M | 65.66M | 67.16M | 89M | 85.92M | 94.19M | 142.42M | 178.61M | 52.53M | 45.51M | 73.85M |
| Accounts Receivable | 11.3M | 11.3M | 7.12M | 6.5M | 15.14M | 9.4M | 0 | 12.29M | 10.87M | 23.68M | 0 | 0 |
| Days Sales Outstanding | 20.74 | 16.97 | 45.39 | 698.03 | - | - | - | - | - | - | - | - |
| Inventory | 3.43M | 3.43M | 458K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 51.89 | 77.6 | 33.92 | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 8.49M | 0 | 19.21M | 0 | 16.49M | 0 | 0 | 0 | 21.3M | 20.57M |
| Total Non-Current Assets | 15.23M | 15.23M | 14.71M | 9.61M | 9.08M | 8.63M | 8.56M | 8.56M | 9.71M | 9.87M | 10.14M | 10.49M |
| Property, Plant & Equipment | 12.86M | 0 | 12.29M | 7.23M | 1.99M | 7.25M | 7.9M | 7.96M | 9.15M | 9.47M | 9.8M | 10.38M |
| Fixed Asset Turnover | 3.25x | - | 1.40x | 0.31x | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 803K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.37M | 14.43M | 2.42M | 2.38M | 7.09M | 1.39M | 662K | 605K | 567K | 397K | 337K | 106K |
| Total Assets | 335.38M | 335.38M | 339.93M | 215.5M | 250.77M | 275.99M | 160.83M | 200.2M | 235.4M | 113.97M | 138.74M | 160.33M |
| Asset Turnover | 0.12x | 0.18x | 0.05x | 0.01x | - | - | - | - | - | - | - | - |
| Asset Growth % | 33.74% | 21.52% | 111.36% | 7.65% | 6.53% | 142.17% | 15.92% | 24.86% | 28.49% | -43.99% | -14.8% | -12.06% |
| Total Current Liabilities | 57.35M | 57.35M | 45.07M | 38.38M | 45.17M | 25.61M | 22.16M | 22.41M | 22.81M | 19.13M | 17.75M | 14.13M |
| Accounts Payable | 8.27M | 8.27M | 8.07M | 5.87M | 4.88M | 5.86M | 5.2M | 10.79M | 9.11M | 3.1M | 4.9M | 5.06M |
| Days Payables Outstanding | 218.21 | 187.15 | 516.36 | 838.29 | 30.07 | - | - | - | 21.76 | 1.78K | 23.99 | 23.53 |
| Short-Term Debt | 0 | 15.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 11.51M | 11.41M | 11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 36.8M | 15.41M | 14.28M | 8.55M | 0 | 9.55M | 6.98M | 3.17M | 0 | 5.46M | 0 | 0 |
| Current Ratio | 5.58x | 5.58x | 7.22x | 5.37x | 5.35x | 10.44x | 6.87x | 8.55x | 9.90x | 5.44x | 7.25x | 10.60x |
| Quick Ratio | 5.52x | 5.52x | 7.21x | 5.37x | 5.35x | 10.44x | 6.87x | 8.55x | 9.90x | 5.44x | 7.25x | 10.60x |
| Cash Conversion Cycle | -145.58 | -92.58 | -437.05 | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 280.73M | 280.73M | 277.86M | 136.34M | 110.21M | 105.25M | 4.67M | 4.99M | 6.01M | 6.26M | 6.55M | 6.87M |
| Long-Term Debt | 139.23M | 258.29M | 139.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 10.73M | 10.73M | 9.13M | 4.02M | 4.33M | 4.34M | 4.67M | 4.99M | 6.01M | 6.26M | 6.55M | 6.87M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 119.06M | 0 | 129.71M | 132.32M | 0 | 100.91M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 338.09M | 338.09M | 322.93M | 174.72M | 155.38M | 130.87M | 26.84M | 27.4M | 28.82M | 25.39M | 24.3M | 21M |
| Total Debt | 151.57M | 284.21M | 149.59M | 6.14M | 6.31M | 5.78M | 6.21M | 6.25M | 7.32M | 7.44M | 7.69M | 7.99M |
| Net Debt | -77.77M | 54.87M | -93.91M | -118.16M | -92.34M | -161.51M | -35.37M | -25.6M | -24.47M | -15.61M | -49.97M | -41.42M |
| Debt / Equity | - | - | 8.80x | 0.15x | 0.07x | 0.04x | 0.05x | 0.04x | 0.04x | 0.08x | 0.07x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -4.20x | -1.33x | -8.95x | -15.45x | -18.70x | -14.57x | - | - | - | - | - | - |
| Total Equity | -2.71M | -2.71M | 17M | 40.79M | 95.39M | 145.13M | 133.99M | 172.8M | 206.58M | 88.58M | 114.45M | 139.34M |
| Equity Growth % | -102.84% | -101.87% | -87.31% | -76.39% | -53.82% | 63.83% | 17.08% | 24.02% | 28.29% | -51.97% | -20.42% | -15.33% |
| Book Value per Share | -0.05 | -0.05 | 0.32 | 0.76 | 1.92 | 2.76 | 2.87 | 3.74 | 4.74 | 2.55 | 3.31 | 4.05 |
| Total Shareholders' Equity | -2.71M | -2.71M | 17M | 40.79M | 95.39M | 145.13M | 133.99M | 172.8M | 206.58M | 88.58M | 114.45M | 139.34M |
| Common Stock | 51K | 51K | 50K | 50K | 50K | 0 | 0 | 43K | 42K | 34K | 34K | 34K |
| Retained Earnings | -762.69M | -762.69M | -739.1M | -713.27M | -653.17M | -600.95M | -552.44M | -510.17M | -469.73M | -425.08M | -396.05M | -368.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -7.13M | -7.13M | -6.73M | -6.39M | -5.21M | -2.21M | -2.7M | -2.87M | -3.49M | -3.29M | -3.46M | -2.89M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |